Prevalence and associations of peripheral neuropathy at disease-onset in ANCA-associated vasculitides: Data from DCVAS study

Prevalence and associations of peripheral neuropathy at disease-onset in ANCA-associated vasculitides: Data from DCVAS study

Bibliographic Details
Main Authors:	Michael, C, Bischof, A, Jaeger, V, Hadden, R, Luqmani, R, Suppiah, R, Craven, A, Thomas, D
Format:	Conference item
Published:	Wiley 2018

Similar Items

THU0306 Prevalence and characteristics of neuropathy in patients with ANCA associated vasculitides: data from the DCVAS study
by: Bischof, A, et al.
Published: (2017)

Classification criteria for the anca-associated vasculitides
by: Robson, J, et al.
Published: (2019)

Association between age at diagnosis and clinical presentation and outcomes of anca-associated vasculitis. analysis from the dcvas study
by: Monti, S, et al.
Published: (2018)

Towards diagnostic criteria for the ANCA-associated vasculitides.
by: Luqmani, R
Published: (2007)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
by: Suppiah, R, et al.
Published: (2011)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
by: Suppiah, R, et al.
Published: (2011)

ANCA-associated vasculitides in childhood
by: Szabó András, et al.
Published: (2011-09-01)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
by: Craven, A, et al.
Published: (2013)

Atherosclerosis in ANCA-associated systemic vasculitides
by: E I Kuznetsova, et al.
Published: (2012-06-01)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
by: Robson, J, et al.
Published: (2013)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
by: Robson, J, et al.
Published: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
by: Robson, J, et al.
Published: (2015)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
by: Luqmani, R, et al.
Published: (2011)

French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
by: Benjamin Terrier, et al.
Published: (2020-12-01)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
by: Robson, J, et al.
Published: (2013)

The role of rituximab in the treatment of ANCA-associated vasculitides (AAV)
by: Thomas Daikeler, et al.
Published: (2015-01-01)

Upper respiratory tract manifestations in patients with ANCA-associated vasculitides and their association with the presence and type of ANCA
by: I. G. Smirnova, et al.
Published: (2021-10-01)

Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
by: Benjamin Terrier, et al.
Published: (2021-04-01)

Outcome measures in ANCA-associated vasculitis.
by: Suppiah, R, et al.
Published: (2010)

International guidelines for the management ofANCA-associated systemic vasculitides
by: T. V. Beketova
Published: (2019-03-01)

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
by: N M Bulanov, et al.
Published: (2018-06-01)

Pulmonary manifestations of primary systemic vasculitides
by: Makhzoum, J, et al.
Published: (2017)

Vasculites associadas ao anticorpo anticitoplasma de neutrófilo (Anca) Vasculitides associated to antineutrophil cytoplasmic antibodies (Anca)
by: Boris A. Cruz
Published: (2007-04-01)

Cutaneous manifestations of ANCA-associated vasculitis
by: Chiesafuxench, Z, et al.
Published: (2016)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
by: Robson, J, et al.
Published: (2013)

SY4_1 Giant cell arteritis (GCA) and Takayasu arteritis (TAK): a spectrum within the same disease or not? A report from the DCVAS project
by: Luqmani, R, et al.
Published: (2017)

A rare case of spontaneous renal rupture caused by ANCA - associated vasculitides
by: Yongquan Yu, et al.

Cutaneous manifestations of ANCA-associated vasculitis are common, varied, and associated with systemic disease
by: Micheletti, R, et al.
Published: (2017)

State of the art in the treatment of systemic vasculitides.
by: Luqmani, R
Published: (2014)

Large vessel vasculitides: update for the cardiologist.
by: Luqmani, R
Published: (2012)

Assessing disease activity in the systemic vasculitides.
by: Luqmani, R
Published: (2002)

Introduction to, and classification of, the systemic vasculitides.
by: Luqmani, R, et al.
Published: (2001)

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary
by: Lucy McGeoch, et al.
Published: (2015-11-01)

Global ethnic and geographic idfferences in the clinical features of ANCA-associated vasculitis
by: Pearce, F, et al.
Published: (2016)

Interest of Procalcitonin in ANCA Vasculitides for Differentiation between Flare and Infections
by: Xavier Poirot-Seynaeve, et al.
Published: (2023-03-01)

Disease assessment and management of the vasculitides.
by: Luqmani, R, et al.
Published: (1997)

Serum Uric Acid Associates with Systemic Complement C3 Activation in Severe ANCA-Associated Renal Vasculitides
by: Eva Baier, et al.
Published: (2024-01-01)

Maintenance of clinical remission in ANCA-associated vasculitis.
by: Luqmani, R
Published: (2013)

Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides
by: Camille Roubille, et al.
Published: (2021-05-01)

Damage assessment in ANCA-associated vasculitis.
by: Bhamra, K, et al.
Published: (2012)